Evidence map›Paper›PMID 33705665›Full record

Trial reportAmerican journal of respiratory and critical care medicine2021

Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.

Antonio Nieto, Angel Mazón, María Nieto, Rafael Calderón, Susana Calaforra, Blanca Selva, Sonia Uixera, Maria José Palao, Paola Brandi, Laura Conejero and 5 more

Registry-linked trialOpen access · greenAbstract readClinical Trial, Phase IIIRandomized Controlled Trial
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05208060 (A Phase I/II Randomized, Prospective, Double-blind, Placebo-controlled, Single-center Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05208060 phase1 / phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

A Phase I/II Randomized, Prospective, Double-blind, Placebo-controlled, Single-center Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells

TypeinterventionalSponsorInmunotek S.L.Ran2023 to 2025Enrolled48ConditionsImmune ResponseArmsMV130, Placebo
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Upper and Lower Respiratory Tract Compartmentalization in Pediatric Stem Cell Transplantation.American journal of respiratory cell and molecular biology · 2026
    Article
  5. Article
  6. Asthma endotypes and theratypes.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  7. Review
  8. Heat-killedFrontiers in immunology · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Frontiers in cellular and infection microbiology · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Antonio NietoUnidad de Neumología y Alergia Pediátrica, Instituto de Investigaciones Sanitarias, Hospital Universitario La Fe, Valencia, Spain.ORCID 0000-0002-6302-6115
Angel MazónUnidad de Neumología y Alergia Pediátrica, Instituto de Investigaciones Sanitarias, Hospital Universitario La Fe, Valencia, Spain.ORCID 0000-0001-5639-1037
María NietoUnidad de Neumología y Alergia Pediátrica, Instituto de Investigaciones Sanitarias, Hospital Universitario La Fe, Valencia, Spain.
Rafael CalderónDepartmento de Pediatría, Manises Hospital, Valencia, Spain.
Susana CalaforraUnidad de Neumología y Alergia Pediátrica, Instituto de Investigaciones Sanitarias, Hospital Universitario La Fe, Valencia, Spain.
Blanca SelvaUnidad de Neumología y Alergia Pediátrica, Instituto de Investigaciones Sanitarias, Hospital Universitario La Fe, Valencia, Spain.
Sonia UixeraUnidad de Neumología y Alergia Pediátrica, Instituto de Investigaciones Sanitarias, Hospital Universitario La Fe, Valencia, Spain.
Maria José PalaoDepartmento de Pediatría, Manises Hospital, Valencia, Spain.
Paola BrandiCentro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
Laura ConejeroInmunotek S.L., Alcalá de Henares, Spain; and.ORCID 0000-0001-6515-9221
Paula Saz-LealInmunotek S.L., Alcalá de Henares, Spain; and.ORCID 0000-0002-6263-4709
Cristina Fernández-PérezInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain.
David SanchoCentro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.ORCID 0000-0003-2890-3984
José Luis SubizaInmunotek S.L., Alcalá de Henares, Spain; and.ORCID 0000-0002-0134-5321
Miguel CasanovasInmunotek S.L., Alcalá de Henares, Spain; and.ORCID 0000-0003-2330-3963
Hospital Universitari i Politècnic La Fe · ESInmunotek (Spain) · ESSpanish National Centre for Cardiovascular Research · ESHospital Clínico San Carlos · ESInstituto de Investigación Sanitaria La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BacteriaRespiratory SoundsChild, PreschoolDouble-Blind MethodFemaleFollow-Up StudiesHumansInfantMaleRecurrenceSecondary PreventionSublingual ImmunotherapyTreatment Outcomeclinical trialmucosal vaccinationMV130wheezing attacks

Identifiers

PMID33705665
PMCPMC8480240
OpenAlexW3133800288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.